Tag Archive for 'current issues'

Page 3 of 3

Autism and insurance in MI

In the US state of Michigan, a major health insurance provider will now reimburse families for the cost of providing therapy for children with autism. The case, Johns v. Blue Cross Blue Shield of Michigan, arose because Blue-Cross-Blue-Shield denied payment for behavioral treatment often called “ABA” to the family of a child with Autism. The case was settled in favor of the family last week.

Represented by Gerard Mantese, Mr. Christopher Johns alleged that the insurer should pay for the therapy for his son under the provisions of the policy. The insurance company refused and Mr. Johns sued. During depositions, Mr. Mantese and others on the Mr. Johns’ legal team learned of a draft memorandum identifying the behavioral therapy as effective and that a representative of the insurer would probably elect the behavioral therapy if that representative had a child with Autism.

Because Mr. Johns’ complaint was part of a class action suit, many other families will also benefit from the settlement. In an independent analysis of the case, Tresa Baldas discussed the implications.

The $1 million class action settlement from Blue Cross Blue Shield of Michigan comes amid a legislative wave in which a growing number of a states are passing laws that require insurance companies to pay for autism treatments and screenings. To date, 13 states have such laws, the most recent being Connecticut, Colorado and Nevada. New Jersey is currently considering an autism bill, and Pennsylvania’s law goes into effect July 1.

The June 17 Michigan settlement, meanwhile, has autism advocates hopeful that insurance companies will stop claiming that behavioral therapy for autistic children is experimental, and start paying for it.

“It is a significant victory for the families, obviously, and it marks a trend, hopefully, that insurance companies will start to look at autism treatment differently,” said Areva Martin, an attorney at Los Angeles-based Martin & Martin who is currently handling about 30 autism cases. She believes the labeling of autism treatments as experimental is “absurd.”

I wonder what this will mean for the California rules that do not expressly exclude behavioral therapies, but set requirements for deciding whether they are reimbursable (see my earlier post on that story).

Link for a quasi-news article about the settlement. Read another of the law firm’s press releases. Here’s link to Ms. Baldas’ analysis of the case.

Sphere: Related Content

CCBD on seclusion and restraint

The Council for Children with Behavior Disorders (CCBD), an international group concerned about children and youths with EBD, published statements about the use of seclusion and restraint with students. Although the documents appear to be in preliminary form, they began circulating on the Internet today, so I’m posting copies of the PDFs here. Watch for an update of them.

Link to the CCBD Web site.

Sphere: Related Content

US Congress hearings on seclusion and restraint

Over on Behavior Mod Info readers can find several entries about the hearings regarding US schools’ use of seclusion and restraint. The hearings were conducted by the US House of Representatives’ Committee on Education and Labor.

(Apologies for the cross-posting to those who read Teach Effectively.)

Sphere: Related Content

Does Rossignol et al. show HBOT’s effective?

“Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial” by Daniel A. Rossignol, Lanier W. Rossignol, Scott Smith, Cindy Schneider, Sally Logerquist, Anju Usman, Jim Neubrander, Eric M. Madren, Gregg Hintz, Barry Grushkin, Elizabeth A. Mumper appeared as an on-line publication 13 March 2009 and will appear in print in BMC Pediatrics. The article URL is http://www.biomedcentral.com/1471-2431/9/21

The recently published study by Rossignol and colleagues about hyperbaric oxygen therapy (HBOT) for Autism has generated lots of commentary and is sure to lead to more. Because it is a treatment study and employs more careful methods than are common in many of the therapies promoted these days, I sat up and said, “Hmm. I ought to read this one.”

So I did. And I found it to be, indeed, a cut above much of the ersatz research that’s passed off as evidence in the Autism arena. But, I found some concerns, too.

Those concerns led me to poke about a bit on the Internet to see whether there were any others who were raising questions. There are. And I still have some more poking to do. But, I thought I ought to record my concerns. Thus this post.

Continue reading ‘Does Rossignol et al. show HBOT’s effective?’

Sphere: Related Content

Autism in Parade

The US magazine Parade, which (along with comics and advertisements) is included in the inserts of many Sunday editions of newspapers, featured a pair of pieces about Autism 27 January. In one of them, Ranit Mishori gives a brief overview of Autism and in the other Suzanne Wright provides a first-person perspective on the effects of Autism on families.

Dr. Mishori, who doubles by practicing family-practice medicine and writing about medical topics for the popular press, addresses these questions:

  • Is Autism an Epidemic?
  • What Is the Best Treatment?
  • Do Vaccines Cause Autism?
  • Is There Hope?
  • Does It Work?

Continue reading ‘Autism in Parade’

Sphere: Related Content




Bad Behavior has blocked 801 access attempts in the last 7 days.